Prostaglandins of the A series were found to strongly suppress the replication of vesicular stomatitis virus (VSV) in mouse L fibroblasts. The highest non-toxic dose of PGA1, 4 µg/ml, decreased VSV production by 93.6%. At this dose, PGA1 did not alter DNA, RNA or protein synthesis in uninfected L cells for periods up to 24 h, whereas it further suppressed protein synthesis and slightly increased RNA synthesis in VSV-infected cells. The presence of PGA1 during virus adsorption, with no treatment after infection, reduced VSV yields by 63.6%. However, the presence of PGA1 during an early step of VSV replication was not essential for the antiviral action to occur (PGA1 treatment could be started 1 to 2 h post-infection). Apart from a slight overall inhibition of virus protein synthesis, PGA1 strongly suppressed the synthesis of the VSV glycoprotein G; moreover, it produced an alteration in the mobility of this protein in SDS-polyacrylamide gels. We propose that this slight decrease in molecular weight (about 4000) of the G protein in the presence of PGA1 could be due to an alteration in the glycosylation process.
ChatisP. A.,
MorrisonT. G.1983; Characterization of the soluble glycoprotein released from vesicular stomatitis virus-infected cells. Journal of Virology 45:80–90
Dore-DuffyP.1982; Differential effect of prostaglandins and other products of arachidonic acid metabolism on measles virus replication in Vero cells. Prostaglandins, Leukothrienes and Medicine 8:73–82
JaffeB. M.,
BehrmanH. R.,
ParkerC. W.1973; Radioimmunoassay measurement of prostaglandins E, A and F in human plasma. Journal of Clinical Investigation 52:398–405
LuczakM.,
GumulkaS.,
SzmigielskiS.,
KorbeckiM.1975; Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated WISH cells. Archives of Virology 49:377–380
MaheshwariR. K.,
BanerjeeD. K.,
WaechterC. J.,
OldenK.,
FriedmanR. M.1980; Interferon treatment inhibits glycosylation of a viral protein. Nature, London 287:454–456
PottathilR.,
ChandraboseK. A.,
CuatrecasasP.,
LangD. J.1980; Establishment of the interferon- mediated antiviral state: role of fatty acid cyclooxygenase. Proceedings of the National Academy of Sciences, U. S. A 77:5437–5440
SantoroM. G.,
CarrubaG.,
GaraciE.,
JaffeB. M.,
BenedettoA.1981; Prostaglandins of the A series inhibit Sendai virus replication in cultured cells. Journal of General Virology 53:75–83
SantoroM. G.,
JaffeB. M.,
GaraciE.,
EstebanM.1982; Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells. Journal of General Virology 63:435–440
SchmidtM. F.,
SchlesingerM. J.1979; Fatty acid binding to vesicular stomatitis virus glycoprotein: a new type of post-translational modification of the viral glycoprotein. Cell 17:813–819
TrofatterK.,
DanielsC.1980; Effect of prostaglandins and cyclic adenosine 3′, 5′-monophosphate modulators on herpes simplex virus growth and interferon response in human cells. Infection and Immunity 27:158–164